Particle.news

Download on the App Store

Anthem Biosciences IPO Fully Subscribes on Day Two as Grey Market Premium Tops ₹100

Strong anchor backing has driven robust subscription that suggests roughly 18% listing gains with allotment set for July 17

Image
Should You Invest In Anthem Biosciences IPO? Top Management Answers Key Investor Questions

Overview

  • The ₹3,395 crore offer-for-sale comprises 5.96 crore existing shares priced in a ₹540–570 per share band.
  • Sixty anchor investors, led by Abu Dhabi Investment Authority and Government Pension Fund Global, committed ₹1,016 crore at the ₹570 upper band.
  • Bidding closed at 1.19 times subscription on July 15, with non-institutional investors at 2.94× and retail at 0.91×.
  • Unofficial grey market premiums near ₹100 imply a probable listing price around ₹670, signaling roughly 18% first-day gains.
  • Share allotment is scheduled for July 17 and the stock is set to debut on the BSE and NSE on July 21.